1. Iatrogenic Toxicities in the Intensive Care Unit
    Lama H. Nazer et al, 2021, Critical Care Clinics CrossRef
  2. Assessment of drug-induced electrolyte disorders in intensive care units: a multicenter observational study
    Yunus Emre Ayhan et al, 2024, Frontiers in Medicine CrossRef
  3. Be an advocate
    Yehudis Appel, 2018, Nursing Critical Care CrossRef
  4. The Japanese Clinical Practice Guideline for acute kidney injury 2016
    null null et al, 2018, Renal Replacement Therapy CrossRef
  5. Is low level of serum phosphorus within normal range a predictive parameter for disease severity in hospitalized COVID-19 patients?
    Müge BİLGE et al, 2022, Turkish Journal of Clinics and Laboratory CrossRef
  6. Hypophosphatemia in Chronic Obstructive Pulmonary Disease Patients Requiring Mechanical Ventilation and Its Impact on Weaning in an Intensive Care Unit of a Tertiary Care Hospital in Eastern India
    Amrita R Kundu et al, 2024, Cureus CrossRef
  7. Association between phosphate disturbances and mortality among critically ill patients with sepsis or septic shock
    Shmeylan A. Al Harbi et al, 2021, BMC Pharmacology and Toxicology CrossRef
  8. Hypophosphatemia on ICU Admission Is Associated with an Increased Length of Stay in the ICU and Time under Mechanical Ventilation
    Hannah Wozniak et al, 2022, Journal of Clinical Medicine CrossRef
  9. Low serum calcium and phosphorus and their clinical performance in detecting COVID‐19 patients
    Caiting Yang et al, 2021, Journal of Medical Virology CrossRef
  10. DYNAMICS OF PHOSPHATE LEVEL AND ADAPTATION POTENTIAL IN THE IMPLEMENTATION OF THE ERAS-PROTOCOL IN OVERWEIGHT PATIENTS WITH A SURGICAL PROFILE
    null Dyachenko Hlib Dmytrovych et al, 2020, World Science CrossRef
  11. Insights into the possible impact of COVID-19 on the endocrine system
    Adel Abdel-Moneim et al, 2023, Archives of Physiology and Biochemistry CrossRef
  12. Hypo- and Hyperphosphatemia at Admission as Independent Factors of Mortality of COVID-19 Patients: Findings from a Retrospective Cohort Study
    Marzieh Hadavi et al, 2022, International Journal of Endocrinology and Metabolism CrossRef
  13. Hypophosphataemia after intravenous iron therapy with ferric carboxymaltose—Real world experience from a tertiary centre in the UK
    Konstantinos C. Fragkos et al, 2020, GastroHep CrossRef
  14. Late and Insufficient Phosphorus Supplementation is Associated with Early Severe Hypophosphatemia in Extremely Low Birth Weight Infants with Early Amino Acid Administration
    Sae Mi Yang et al, 2018, Perinatology CrossRef
  15. Impact of hypophosphatemia on outcome of patients in intensive care unit: a retrospective cohort study
    Lichun Wang et al, 2019, BMC Anesthesiology CrossRef
  16. Preventative and therapeutic potential of animal milk components against COVID‐19: A comprehensive review
    Parminder Singh et al, 2023, Food Science & Nutrition CrossRef
  17. Hypophosphatemia in critically ill adults and children – A systematic review
    Annika Reintam Blaser et al, 2021, Clinical Nutrition CrossRef
  18. Serum levels of alpha-melanocyte stimulating hormone, vitamin D, calcium, phosphorus and magnesium in COVID-19 patients
    null null et al, 2021, The Ukrainian Biochemical Journal CrossRef
  19. The Japanese Clinical Practice Guideline for acute kidney injury 2016
    null null et al, 2018, Journal of Intensive Care CrossRef
  20. The Japanese clinical practice guideline for acute kidney injury 2016
    null null et al, 2018, Clinical and Experimental Nephrology CrossRef
  21. The prognostic value of hypophosphatemia in acute exacerbation of chronic obstructive pulmonary disease (COPD)
    Ibrahim El-Sayed et al, 2017, The Egyptian Journal of Critical Care Medicine CrossRef
  22. Role and knowledge of critical care nurses in the assessment and management of hypophosphataemia and refeeding syndrome. A descriptive exploratory study
    Hadas Ben-Tovim et al, 2021, Intensive and Critical Care Nursing CrossRef
  23. Newer formulations of intravenous iron: a review of their chemistry and key safety aspects – hypersensitivity, hypophosphatemia, and cardiovascular safety
    Irina Blumenstein et al, 2021, Expert Opinion on Drug Safety CrossRef